Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Author: Clinical Editor

Koala trial doses first patient with novel KMA‑targeting CAR‑T

Koala trial doses first patient with novel KMA‑targeting CAR‑T
p p Read More

Australian teams advance first‑in‑human multiple myeloma therapy

September 2, 2026 News

Heparegenix wins orphan drug status for darizmetinib

Heparegenix wins orphan drug status for darizmetinib
p p Read More

Designation supports development for post‑hepatectomy liver failure

September 2, 2026 News

US heatwaves: nearly 1 in 10 emergency department visits heat related, study finds

Almost a tenth of visits to emergency departments (EDs) during heatwaves in the US last year were heat […]

September 2, 2026 Uncategorized

GP AI receptionist failing to understand patients with accents, report warns

An artificial intelligence receptionist system for general practices, which responds poorly to regional accents and speech impediments, could […]

September 2, 2026 Uncategorized

UK childhood vaccination rates fall in babies but stabilise at age 5

Vaccination rates to protect babies against severe illness have fallen again in the UK, official data show.1 However, […]

September 2, 2026 Uncategorized

Civility is the foundation of patient safety in surgery

Working in the operating theatre can be stressful and lead to heightened emotions, frustration, and short tempered outbursts. […]

September 2, 2026 Uncategorized

Health and the city: why urban health systems need greater authority

Around four billion people, just over half the global population, live in urban areas. This proportion is projected […]

September 1, 2026 Uncategorized

Building a stronger NHS: an open letter from past and present presidents and chairs of the Royal College of General Practitioners

The NHS is at a pivotal point. As legislation proceeds through parliament, the Department of Health and Social […]

September 1, 2026 Uncategorized

IMAVVY approved as first targeted therapy for wAIHA

IMAVVY approved as first targeted therapy for wAIHA
p p Read More

New treatment reduces pathogenic IgG while preserving B‑cell function

September 1, 2026 News

Nxera partner gains acceptance for NBI‑1117567

Nxera partner gains acceptance for NBI‑1117567
p p Read More

Phase 2 study to assess muscarinic M1 agonist in Alzheimer’s cognition

September 1, 2026 News

Posts navigation

« Previous

Posts pagination

1 2 … 2,033 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy